Elevated IL6 levels have been linked to glioma growth, with hypoxia-induced IL6 secretion enhancing GBM autophagy; hence, targeted inhibition by tocilizumab can prevent GBM progression and autophagy [38]. This evidence concerns the gene IL6 and glioblastoma.